Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
Study Information
Alliance Study ID: CALGB-100101
NCT Study ID (ClinicalTrials.gov): NCT00074035
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Sherif S. Farag, MD, PhD
Status: COMPLETED
Study Description
RATIONALE: Pentostatin may be effective in treating chronic graft-versus-host disease by stopping the immune system from rejecting donor stem cells or donor white blood cells.
PURPOSE: This phase II trial is studying how well pentostatin works in treating patients with chronic graft-versus-host disease that is refractory (not responsive) to treatment with steroids.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information